Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Peripheral Arterial Hemorrhage With Lava LES (The LAVA Study)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age ≥18 years;~* Active arterial bleeding in the peripheral vasculature, documented on a suitable imaging study;~* Subject or subject's legally authorized representative is able and authorized to provide written informed consent for the procedure and the study;~* Subject is willing and able to comply with the specified follow-up evaluation schedule;~* Life expectancy \>30 days;~* No prior embolization in the target territory.~Exclusion Criteria:~* Pregnancy or breast feeding. A woman who, in the Investigator's opinion, is of child-bearing potential must have a negative pregnancy test within 7 days before the index procedure;~* Coexisting signs of peritonitis or other active infection;~* Participation in an investigational study of a new drug, biologic or device that has not reached its primary endpoint at the time of study screening;~* Uncorrectable coagulopathies such as thrombocytopenia \<40,000/ μL, international normalization ratio (INR) \>2.0;~* Contraindication to angiography or catheterization, including untreatable allergy to iodinated contrast media;~* Anatomic arterial unsuitability such that, in the Investigator's opinion, the delivery catheter cannot gain access to the selected position for safe and intended embolization;~* Known allergy or other contraindication to any components of Lava LES including dimethyl sulfoxide (DMSO);~* More than 4 Target Lesions will require embolization, in the Investigator's opinion after performance of diagnostic angiography or another suitable imaging study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Lava LES (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).